{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:07:09Z","timestamp":1766074029838,"version":"3.48.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-025-07285-4","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T14:25:59Z","timestamp":1764858359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral-associated bacteria in the gut microbiome of individuals with type 2 diabetes: a secondary analysis of metagenomic data"],"prefix":"10.1186","volume":"25","author":[{"given":"Ricardo","family":"Franco-Duarte","sequence":"first","affiliation":[]},{"given":"Zaki","family":"Saati-Santamar\u00eda","sequence":"additional","affiliation":[]},{"given":"Phannaphat","family":"Choowong","sequence":"additional","affiliation":[]},{"given":"Gangani","family":"Dharmarathne","sequence":"additional","affiliation":[]},{"given":"Esther","family":"Men\u00e9ndez","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Rito","sequence":"additional","affiliation":[]},{"given":"Wah","family":"Cheung","sequence":"additional","affiliation":[]},{"given":"Axel","family":"Spahr","sequence":"additional","affiliation":[]},{"given":"Joerg","family":"Eberhard","sequence":"additional","affiliation":[]},{"given":"Thilini N","family":"Jayasinghe","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"7285_CR1","volume-title":"Type 2 diabetes (Nursing)","author":"R Goyal","year":"2023","unstructured":"Goyal R, Singhal M, Jialal I, Castano M. Type 2 diabetes (Nursing). In:\u00a0StatPearls. Treasure Island (FL): StatPearls Publishing; 2023."},{"key":"7285_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-3-031-31307-3_27","volume-title":"Managing psychosexual consequences in chronic diseases","author":"M Belluz","year":"2023","unstructured":"Belluz M, Longhi EV. Periodontal disease. Managing psychosexual consequences in chronic diseases. Cham: Springer International Publishing; 2023. pp. 329\u201336. https:\/\/doi.org\/10.1007\/978-3-031-31307-3_27."},{"key":"7285_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2023.2197779","author":"AA Abdulkareem","year":"2023","unstructured":"Abdulkareem AA, et al. Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis. J Oral Microbiol. 2023. https:\/\/doi.org\/10.1080\/20002297.2023.2197779.","journal-title":"J Oral Microbiol"},{"key":"7285_CR4","doi-asserted-by":"crossref","unstructured":"Rehman K, Akash MSH. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? Journal of Biomedical Science 2016 23:1 23, 1\u201318 (2016).","DOI":"10.1186\/s12929-016-0303-y"},{"key":"7285_CR5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ni.2635","volume":"14","author":"H Chu","year":"2013","unstructured":"Chu H, Mazmanian SK. Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat Immunol. 2013;14:668.","journal-title":"Nat Immunol"},{"key":"7285_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s13167-019-00163-4","volume":"10","author":"JC Yu","year":"2019","unstructured":"Yu JC, Khodadadi H, Baban B. Innate immunity and oral microbiome: a personalized, predictive, and preventive approach to the management of oral diseases. EPMA J. 2019;10:43.","journal-title":"EPMA J"},{"key":"7285_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41415-019-0794-5","volume":"227","author":"PM Preshaw","year":"2019","unstructured":"Preshaw PM, Bissett SM. Periodontitis and diabetes. Br Dent J. 2019;227:577\u201384.","journal-title":"Br Dent J"},{"key":"7285_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S2213-8587(18)30038-X","volume":"6","author":"F D\u2019Aiuto","year":"2018","unstructured":"D\u2019Aiuto F, et al. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diabetes Endocrinol. 2018;6:954\u201365.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7285_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1034\/j.1600-051x.2001.028004306.x","volume":"28","author":"JE Stewart","year":"2001","unstructured":"Stewart JE, Wager KA, Friedlander AH, Zadeh HH. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol. 2001;28:306\u201310.","journal-title":"J Clin Periodontol"},{"key":"7285_CR10","doi-asserted-by":"crossref","unstructured":"Simpson TC, Weldon JC, Worthington HV, Needleman I, Wild SH, Moles DR, Stevenson B, Furness S, Iheozor-Ejiofor Z. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus. Cochrane Database Syst Rev. 2015;2015(11):CD004714.","DOI":"10.1002\/14651858.CD004714.pub3"},{"key":"7285_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1834-7819.2010.01273.x","volume":"55","author":"T Simpson","year":"2010","unstructured":"Simpson T, Needleman I, Wild S, Moles D, Mills E. Treatment of periodontal disease for glycaemic control in people with diabetes. Aust Dent J. 2010;55:472\u20134.","journal-title":"Aust Dent J"},{"key":"7285_CR12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/diagnostics11081376","volume":"11","author":"C Thomas","year":"2021","unstructured":"Thomas C, et al. Oral microbiota: a major player in the diagnosis of systemic diseases. Diagnostics. 2021;11:1376.","journal-title":"Diagnostics"},{"key":"7285_CR13","doi-asserted-by":"publisher","first-page":"1010368","DOI":"10.3389\/fimmu.2022.1010368","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, et al. The oral microbiota and cardiometabolic health: a comprehensive review and emerging insights. Front Immunol. 2022;13:1010368.","journal-title":"Front Immunol"},{"key":"7285_CR14","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/biomedicines10081803","volume":"10","author":"B Giordano-Kelhoffer","year":"2022","unstructured":"Giordano-Kelhoffer B, et al. Oral microbiota, its equilibrium and implications in the pathophysiology of human diseases: a systematic review. Biomedicines. 2022;10:1803.","journal-title":"Biomedicines"},{"key":"7285_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00460-18","author":"T Kato","year":"2018","unstructured":"Kato T, et al. Oral administration of Porphyromonas gingivalis alters the gut microbiome and serum metabolome. mSphere. 2018. https:\/\/doi.org\/10.1128\/mSphere.00460-18.","journal-title":"mSphere"},{"key":"7285_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2019.1586422","volume":"11","author":"I Olsen","year":"2019","unstructured":"Olsen I, Yamazaki K. Can oral bacteria affect the microbiome of the gut? J Oral Microbiol. 2019;11:1586422.","journal-title":"J Oral Microbiol"},{"key":"7285_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092124","volume":"13","author":"S-Y Park","year":"2021","unstructured":"Park S-Y, et al. Oral\u2013Gut microbiome axis in Gastrointestinal disease and cancer. Cancers (Basel). 2021;13:2124.","journal-title":"Cancers (Basel)"},{"key":"7285_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1034\/j.1600-0757.2002.280102.x","volume":"28","author":"SS SOCRANSKY","year":"2002","unstructured":"SOCRANSKY SS, HAFFAJEE AD. Dental biofilms: difficult therapeutic targets. Periodontol 2000. 2002;28:12\u201355.","journal-title":"Periodontol 2000"},{"key":"7285_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1177\/00220345580370041701","volume":"37","author":"RL Richardson","year":"1958","unstructured":"Richardson RL, Jones MA. Bacteriologic census of human saliva. J Dent Res. 1958;37:697\u2013709.","journal-title":"J Dent Res"},{"key":"7285_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2020.1820292","author":"\u00c2 Ger\u00f3s-Mesquita","year":"2020","unstructured":"Ger\u00f3s-Mesquita \u00c2, et al. Oral Candida albicans colonization in healthy individuals: prevalence, genotypic diversity, stability along time and transmissibility. J Oral Microbiol. 2020. https:\/\/doi.org\/10.1080\/20002297.2020.1820292.","journal-title":"J Oral Microbiol"},{"key":"7285_CR21","doi-asserted-by":"crossref","unstructured":"Menzel P, Ng KL, Krogh A. Fast and sensitive taxonomic classification for metagenomics with Kaiju. Nature Communications 2016 7:1 7, 1\u20139 (2016).","DOI":"10.1038\/ncomms11257"},{"key":"7285_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-023-12627-9","author":"C Santos-Pereira","year":"2023","unstructured":"Santos-Pereira C, et al. Functional and sequence-based metagenomics to uncover carbohydrate-degrading enzymes from composting samples. Appl Microbiol Biotechnol. 2023. https:\/\/doi.org\/10.1007\/s00253-023-12627-9.","journal-title":"Appl Microbiol Biotechnol"},{"key":"7285_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-50891-x","volume":"14","author":"A Chopra","year":"2024","unstructured":"Chopra A, et al. Exploring the presence of oral bacteria in non-oral sites of patients with cardiovascular diseases using whole metagenomic data. Sci Rep. 2024;14:1\u201313.","journal-title":"Sci Rep"},{"key":"7285_CR24","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1128\/JB.00542-10","volume":"192","author":"FE Dewhirst","year":"2010","unstructured":"Dewhirst FE, et al. The human oral Microbiome. J Bacteriol. 2010;192:5002\u201317.","journal-title":"J Bacteriol"},{"key":"7285_CR25","unstructured":"Veritas Health Innovation. Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation; 2024. Available from:\u00a0https:\/\/www.covidence.org."},{"key":"7285_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Wang","year":"2012","unstructured":"Wang J, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55\u201360.","journal-title":"Nature"},{"key":"7285_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.598672","author":"L Wang","year":"2021","unstructured":"Wang L, et al. The fecal microbiota is already altered in normoglycemic individuals who go on to have type 2 diabetes. Front Cell Infect Microbiol. 2021. .https:\/\/doi.org\/10.3389\/fcimb.2021.598672","journal-title":"Front Cell Infect Microbiol"},{"key":"7285_CR28","doi-asserted-by":"crossref","unstructured":"Zhang Y et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nature Communications 2020 11:1 11, 1\u201312 (2020).","DOI":"10.1038\/s41467-020-18414-8"},{"key":"7285_CR29","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1007\/s11695-020-04684-0","volume":"30","author":"N Davies","year":"2020","unstructured":"Davies N, O\u2019Sullivan JM, Plank LD, Murphy R. Gut microbial predictors of type 2 diabetes remission following bariatric surgery. Obes Surg. 2020;30:3536\u201348.","journal-title":"Obes Surg"},{"key":"7285_CR30","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/gutjnl-2020-323617","volume":"71","author":"SC Ng","year":"2022","unstructured":"Ng SC, et al. Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial. Gut. 2022;71:716\u201323.","journal-title":"Gut"},{"key":"7285_CR31","doi-asserted-by":"crossref","unstructured":"Sun L et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nature Medicine 2018 24:12 24, 1919\u20131929 (2018).","DOI":"10.1038\/s41591-018-0222-4"},{"key":"7285_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241338","author":"I Elbere","year":"2020","unstructured":"Elbere I, et al. Baseline gut microbiome composition predicts Metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients. PLoS One. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0241338.","journal-title":"PLoS One"},{"key":"7285_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100536","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes. Adv Sci. 2021. https:\/\/doi.org\/10.1002\/advs.202100536.","journal-title":"Adv Sci"},{"key":"7285_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0312-1","author":"A Palleja","year":"2016","unstructured":"Palleja A, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med. 2016. https:\/\/doi.org\/10.1186\/s13073-016-0312-1.","journal-title":"Genome Med"},{"key":"7285_CR35","doi-asserted-by":"crossref","unstructured":"Hou K et al. Microbiota in health and diseases. Signal Transduction and Targeted Therapy 2022 7:1 7, 1\u201328 (2022).","DOI":"10.1038\/s41392-022-00974-4"},{"key":"7285_CR36","first-page":"442","volume":"16","author":"A Berbudi","year":"2020","unstructured":"Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16:442.","journal-title":"Curr Diabetes Rev"},{"key":"7285_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41232-023-00304-3","volume":"43","author":"S Kitamoto","year":"2023","unstructured":"Kitamoto S, Kamada N. The oral-gut axis: a missing piece in the IBD puzzle. Inflamm Regen. 2023;43:1\u20139.","journal-title":"Inflamm Regen"},{"key":"7285_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/S41579-024-01075-5","author":"BJ Kunath","year":"2024","unstructured":"Kunath BJ, De Rudder C, Laczny CC, Letellier E, Wilmes P. The oral-gut Microbiome axis in health and disease. Nat Rev Microbiol. 2024. https:\/\/doi.org\/10.1038\/S41579-024-01075-5.","journal-title":"Nat Rev Microbiol"},{"key":"7285_CR39","doi-asserted-by":"crossref","unstructured":"Ray K. The oral\u2013gut axis in IBD. Nature Reviews Gastroenterology & Hepatology 2020 17:9 17, 532\u2013532 (2020).","DOI":"10.1038\/s41575-020-0346-0"},{"key":"7285_CR40","doi-asserted-by":"publisher","first-page":"497714","DOI":"10.3389\/fcimb.2020.00063","volume":"10","author":"AP Doumatey","year":"2020","unstructured":"Doumatey AP, et al. Gut microbiome profiles are associated with type 2 diabetes in urban Africans. Front Cell Infect Microbiol. 2020;10:497714.","journal-title":"Front Cell Infect Microbiol"},{"key":"7285_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009085","author":"N Larsen","year":"2010","unstructured":"Larsen N, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010. https:\/\/doi.org\/10.1371\/journal.pone.0009085.","journal-title":"PLoS One"},{"key":"7285_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2340487","volume":"16","author":"J Gong","year":"2024","unstructured":"Gong J, et al. Effects of prevotella Copri on insulin, gut microbiota and bile acids. Gut Microbes. 2024;16:2340487.","journal-title":"Gut Microbes"},{"key":"7285_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00532-24","author":"C Yang","year":"2024","unstructured":"Yang C, et al. Prevotella copri alleviates hyperglycemia and regulates gut microbiota and metabolic profiles in mice. mSystems. 2024. https:\/\/doi.org\/10.1128\/msystems.00532-24.","journal-title":"mSystems"},{"key":"7285_CR44","doi-asserted-by":"publisher","first-page":"e2118811","DOI":"10.1001\/jamanetworkopen.2021.18811","volume":"4","author":"Z Chen","year":"2021","unstructured":"Chen Z, et al. Association of insulin resistance and type 2 diabetes with gut microbial diversity: a microbiome-wide analysis from population studies. JAMA Netw Open. 2021;4:e2118811-2118811.","journal-title":"JAMA Netw Open"},{"key":"7285_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-024-03496-x","volume":"24","author":"R Khan","year":"2024","unstructured":"Khan R, Sharma A, Ravikumar R, Sivaprasad S, Raman R. Correlation of gut microbial diversity to sight-threatening diabetic retinopathy. BMC Microbiol. 2024;24:1\u20138.","journal-title":"BMC Microbiol"},{"key":"7285_CR46","doi-asserted-by":"publisher","first-page":"e22117","DOI":"10.1016\/j.heliyon.2023.e22117","volume":"9","author":"Q Guo","year":"2023","unstructured":"Guo Q. Bioinformatics analysis of the diversity of gut microbiota and different microbiota on insulin resistance in diabetes mellitus patients. Heliyon. 2023;9:e22117.","journal-title":"Heliyon"},{"key":"7285_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.hnm.2024.200286","volume":"38","author":"D Menafra","year":"2024","unstructured":"Menafra D, Progan\u00f2 M, Tecce N, Pivonello R, Colao A. Diet and gut microbiome: impact of each factor and mutual interactions on prevention and treatment of type 1, type 2, and gestational diabetes mellitus. Human Nutrition & Metabolism. 2024;38:200286.","journal-title":"Human Nutrition & Metabolism"},{"key":"7285_CR48","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42693","author":"TSB Schmidt","year":"2019","unstructured":"Schmidt TSB, et al. Extensive transmission of microbes along the Gastrointestinal tract. Elife. 2019. https:\/\/doi.org\/10.7554\/eLife.42693.","journal-title":"Elife"},{"key":"7285_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-023-02096-9","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Oral-gut microbial transmission promotes diabetic coronary heart disease. Cardiovasc Diabetol. 2024;23:1\u201320.","journal-title":"Cardiovasc Diabetol"},{"key":"7285_CR50","doi-asserted-by":"crossref","unstructured":"Chopra A et al. Exploring the presence of oral bacteria in non-oral sites of patients with cardiovascular diseases using whole metagenomic data. Scientific Reports 2024 14:1 14, 1\u201313 (2024).","DOI":"10.1038\/s41598-023-50891-x"},{"key":"7285_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1010368","author":"Y Li","year":"2022","unstructured":"Li Y, et al. The oral microbiota and cardiometabolic health: a comprehensive review and emerging insights. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.1010368.","journal-title":"Front Immunol"},{"key":"7285_CR52","doi-asserted-by":"publisher","DOI":"10.3402\/jom.v2i0.5781","author":"SJ Leishman","year":"2010","unstructured":"Leishman SJ, Do HL, Ford PJ. Cardiovascular disease and the role of oral bacteria. J Oral Microbiol. 2010. https:\/\/doi.org\/10.3402\/jom.v2i0.5781.","journal-title":"J Oral Microbiol"},{"key":"7285_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuac008","volume":"46","author":"E Foster-Nyarko","year":"2022","unstructured":"Foster-Nyarko E, Pallen MJ. The microbial ecology of Escherichia coli in the vertebrate gut. FEMS Microbiol Rev. 2022;46:fuac008.","journal-title":"FEMS Microbiol Rev"},{"key":"7285_CR54","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1177\/0022034520924633","volume":"99","author":"S Kitamoto","year":"2020","unstructured":"Kitamoto S, Nagao-Kitamoto H, Hein R, Schmidt TM, Kamada N. The bacterial connection between the oral cavity and the gut diseases. J Dent Res. 2020;99:1021.","journal-title":"J Dent Res"},{"key":"7285_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1126\/science.aan4526","volume":"358","author":"K Atarashi","year":"2017","unstructured":"Atarashi K, et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science. 2017;358:359\u201365.","journal-title":"Science"},{"key":"7285_CR56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4161\/gmic.27129","volume":"5","author":"SE Winter","year":"2014","unstructured":"Winter SE, B\u00e4umler AJ. Dysbiosis in the inflamed intestine: chance favors the prepared microbe. Gut Microbes. 2014;5:71\u20133.","journal-title":"Gut Microbes"},{"key":"7285_CR57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/19490976.2019.1629235","volume":"11","author":"M Stephens","year":"2020","unstructured":"Stephens M, von der Weid PY. Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner. Gut Microbes. 2020;11:421\u201332.","journal-title":"Gut Microbes"},{"key":"7285_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2021.697428","volume":"2","author":"TdeC Negrini","year":"2021","unstructured":"Negrini TdeC, Carlos Z, Duque I, Sampaio Caiaffa C, Alex Arthur R. Interplay among the oral microbiome, oral cavity conditions, the host immune response, diabetes mellitus, and its associated-risk factors\u2014an overview. Front Oral Health. 2021;2:697428.","journal-title":"Front Oral Health"},{"key":"7285_CR59","doi-asserted-by":"publisher","first-page":"e0050923","DOI":"10.1128\/iai.00509-23","volume":"92","author":"BP Darwitz","year":"2024","unstructured":"Darwitz BP, Genito CJ, Thurlow LR. Triple threat: how diabetes results in worsened bacterial infections. Infect Immun. 2024;92:e0050923.","journal-title":"Infect Immun"},{"key":"7285_CR60","doi-asserted-by":"publisher","first-page":"1289452","DOI":"10.3389\/fcimb.2023.1289452","volume":"13","author":"SC Tortora","year":"2023","unstructured":"Tortora SC, Agurto MG, Martello LA. The oral-gut-circulatory axis: from homeostasis to colon cancer. Front Cell Infect Microbiol. 2023;13:1289452.","journal-title":"Front Cell Infect Microbiol"},{"issue":"14","key":"7285_CR61","first-page":"1","volume":"14:1","author":"MT Elghannam","year":"2024","unstructured":"Elghannam MT, et al. Oral Microbiome dysbiosis and Gastrointestinal diseases: a narrative review. Egypt Liver J 2024. 2024;14:1(14):1\u20139.","journal-title":"Egypt Liver J 2024"},{"key":"7285_CR62","doi-asserted-by":"publisher","first-page":"154892","DOI":"10.1016\/j.cyto.2019.154892","volume":"126","author":"T Mahlangu","year":"2020","unstructured":"Mahlangu T, et al. A systematic review on the functional role of Th1\/Th2 cytokines in type 2 diabetes and related metabolic complications. Cytokine. 2020;126:154892.","journal-title":"Cytokine"},{"key":"7285_CR63","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1590\/s0004-2803.230402023-86","volume":"60","author":"LJ Andrade","year":"2023","unstructured":"Andrade LJ, de OLIVEIRA O. OLIVEIRA, L. M. THE CONNECTION BETWEEN BILE ACIDS AND TYPE 2 DIABETES MELLITUS - A REVIEW. Arq Gastroenterol. 2023;60:536\u201342. de.","journal-title":"Arq Gastroenterol"},{"key":"7285_CR64","first-page":"3","volume":"41","author":"R Hillson","year":"2024","unstructured":"Hillson R. The stomach in diabetes. Pract Diab. 2024;41:3\u20135.","journal-title":"Pract Diab"},{"key":"7285_CR65","doi-asserted-by":"publisher","first-page":"13548","DOI":"10.1038\/srep13548","volume":"5","author":"H Sugahara","year":"2015","unstructured":"Sugahara H, et al. Probiotic bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community. Sci Rep. 2015;5:13548.","journal-title":"Sci Rep"},{"key":"7285_CR66","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jff.2019.02.002","volume":"54","author":"CB Wong","year":"2019","unstructured":"Wong CB, Odamaki T, Xiao Jzhong. Beneficial effects of bifidobacterium longum subsp. longum BB536 on human health: modulation of gut microbiome as the principal action. J Funct Foods. 2019;54:506\u201319.","journal-title":"J Funct Foods"},{"key":"7285_CR67","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1128\/AEM.03021-10","volume":"77","author":"G Kaci","year":"2011","unstructured":"Kaci G, et al. Inhibition of the NF-\u03baB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius. Appl Environ Microbiol. 2011;77:4681.","journal-title":"Appl Environ Microbiol"},{"key":"7285_CR68","doi-asserted-by":"crossref","unstructured":"Perera D, et al. Impaired host response and the presence of Acinetobacter baumannii in the serum microbiome of type-II diabetic patients. iScience. 2021;24(4):102356.","DOI":"10.1016\/j.isci.2020.101941"},{"key":"7285_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261032","volume":"16","author":"V DeClercq","year":"2021","unstructured":"DeClercq V, Nearing JT, Langille MG. I. Investigation of the impact of commonly used medications on the oral Microbiome of individuals living without major chronic conditions. PLoS One. 2021;16:e0261032.","journal-title":"PLoS One"},{"key":"7285_CR70","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1177\/0022034520926126","volume":"99","author":"SE Kleinstein","year":"2020","unstructured":"Kleinstein SE, Nelson KE, Freire M. Inflammatory networks linking oral microbiome with systemic health and disease. J Dent Res. 2020;99:1131.","journal-title":"J Dent Res"},{"key":"7285_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127055","volume":"261","author":"A Gupta","year":"2022","unstructured":"Gupta A, et al. Oral dysbiosis and its linkage with SARS-CoV-2 infection. Microbiol Res. 2022;261:127055.","journal-title":"Microbiol Res"},{"key":"7285_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2023.100625","volume":"47","author":"X Zhou","year":"2023","unstructured":"Zhou X, Zhang X, Yu J. Gut mycobiome in metabolic diseases: mechanisms and clinical implication. Biomed J. 2023;47:100625.","journal-title":"Biomed J"},{"key":"7285_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126242","volume":"22","author":"M Candelli","year":"2021","unstructured":"Candelli M, et al. Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases. Int J Mol Sci. 2021;22:6242.","journal-title":"Int J Mol Sci"},{"key":"7285_CR74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121.","journal-title":"Cell"},{"key":"7285_CR75","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2018.33.1","volume":"14","author":"S Tsalamandris","year":"2019","unstructured":"Tsalamandris S, et al. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol Rev. 2019;14:50.","journal-title":"Eur Cardiol Rev"},{"key":"7285_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/biom12050642","author":"A Chopra","year":"2022","unstructured":"Chopra A, Jayasinghe TN, Eberhard J. Are inflamed periodontal tissues endogenous source of advanced glycation end-products (AGEs) in individuals with and without diabetes mellitus? A systematic review. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12050642.","journal-title":"Biomolecules"},{"key":"7285_CR77","doi-asserted-by":"crossref","unstructured":"Banavar SR, Tan EL, Davamani F, Khoo SP. Periodontitis and lipopolysaccharides: How far have we understood? Open Exploration 2019 4:1 4, 129\u2013151 (2024).","DOI":"10.37349\/ei.2024.00133"},{"key":"7285_CR78","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03796-22","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Dysbiosis of oral microbiota and metabolite profiles associated with type 2 diabetes mellitus. Microbiol Spectr. 2023. https:\/\/doi.org\/10.1128\/spectrum.03796-22.","journal-title":"Microbiol Spectr"},{"key":"7285_CR79","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.csbj.2021.02.010","volume":"19","author":"A Radaic","year":"2021","unstructured":"Radaic A, Kapila YL. The oralome and its dysbiosis: new insights into oral microbiome-host interactions. Comput Struct Biotechnol J. 2021;19:1335\u201360.","journal-title":"Comput Struct Biotechnol J"},{"key":"7285_CR80","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/omi.12317","volume":"36","author":"TK Nemoto","year":"2020","unstructured":"Nemoto TK, Ohara Nemoto Y. Dipeptidyl-peptidases: key enzymes producing entry forms of extracellular proteins in asaccharolytic periodontopathic bacterium Porphyromonas gingivalis. Mol Oral Microbiol. 2020;36:145.","journal-title":"Mol Oral Microbiol"},{"key":"7285_CR81","doi-asserted-by":"crossref","unstructured":"Liu F et al. Gingipain from Porphyromonas gingivalis causes insulin resistance by degrading insulin receptors through direct proteolytic effects. International Journal of Oral Science 2024 16:1 16, 1\u201314 (2024).","DOI":"10.1038\/s41368-024-00313-z"},{"key":"7285_CR82","doi-asserted-by":"publisher","first-page":"1209381","DOI":"10.3389\/fcimb.2023.1209381","volume":"13","author":"S Jia","year":"2023","unstructured":"Jia S, Li X, Du Q. Host insulin resistance caused by Porphyromonas gingivalis-review of recent progresses. Front Cell Infect Microbiol. 2023;13:1209381.","journal-title":"Front Cell Infect Microbiol"},{"key":"7285_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.4947","volume":"47","author":"W Wang","year":"2021","unstructured":"Wang W, Zhong X, Guo J. Role of 2-series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non-alcoholic fatty liver disease (Review). Int J Mol Med. 2021;47:1\u201315.","journal-title":"Int J Mol Med"},{"key":"7285_CR84","doi-asserted-by":"publisher","first-page":"e0134234","DOI":"10.1371\/journal.pone.0134234","volume":"10","author":"M Nakajima","year":"2015","unstructured":"Nakajima M, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of Enterobacteria to the liver. PLoS One. 2015;10:e0134234.","journal-title":"PLoS One"},{"key":"7285_CR85","doi-asserted-by":"publisher","first-page":"457597","DOI":"10.3389\/fcimb.2019.00244","volume":"9","author":"MASC Picarelli","year":"2019","unstructured":"Picarelli MASC, et al. Extreme diversity of mycoviruses present in isolates of rhizoctonia Solani AG2-2 LP from Zoysia Japonica from Brazil. Front Cell Infect Microbiol. 2019;9:457597.","journal-title":"Front Cell Infect Microbiol"},{"key":"7285_CR86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.syapm.2017.11.008","volume":"41","author":"MY Lim","year":"2018","unstructured":"Lim MY, Song EJ, Kim SH, Lee J, Nam Y. Comparison of DNA extraction methods for human gut microbial community profiling. Syst Appl Microbiol. 2018;41:151\u20137.","journal-title":"Syst Appl Microbiol"},{"key":"7285_CR87","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ebiom.2018.11.046","volume":"39","author":"A Whang","year":"2019","unstructured":"Whang A, Nagpal R, Yadav H. Bi-directional drug-microbiome interactions of anti-diabetics. EBioMedicine. 2019;39:591\u2013602.","journal-title":"EBioMedicine"},{"key":"7285_CR88","doi-asserted-by":"publisher","first-page":"2415487","DOI":"10.1080\/19490976.2024.2415487","volume":"16","author":"J She","year":"2024","unstructured":"She J, et al. A gut feeling of Statin. Gut Microbes. 2024;16:2415487.","journal-title":"Gut Microbes"},{"key":"7285_CR89","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/gutjnl-2023-330168","volume":"73","author":"J Zhu","year":"2023","unstructured":"Zhu J, et al. Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial. Gut. 2023;73:1087.","journal-title":"Gut"},{"key":"7285_CR90","doi-asserted-by":"publisher","first-page":"101805","DOI":"10.1016\/j.molmet.2023.101805","volume":"77","author":"I Pavlo Petakh, Kamyshna","year":"2023","unstructured":"Pavlo Petakh, Kamyshna I, Kamyshnyi A. Effects of Metformin on the gut microbiota: A systematic review. Mol Metab. 2023;77:101805.","journal-title":"Mol Metab"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-07285-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-025-07285-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-07285-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:02:37Z","timestamp":1766073757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-025-07285-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7285"],"URL":"https:\/\/doi.org\/10.1186\/s12903-025-07285-4","relation":{},"ISSN":["1472-6831"],"issn-type":[{"type":"electronic","value":"1472-6831"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for submission and publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1915"}}